Fact CheckerSign in

NCT06315894Completed

Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)

Design and Implementation of a Supervised Computerized Active Program (SuperCAP) for Improvement of Cognitive, Emotional, and Functional Status in People With Post-COVID Syndrome. SuperCAP Study

Source: ClinicalTrials.gov · Last updated 30 Dec 2025

Brief summary (registry, in English)

SuperCAP study is a project aimed at designing and implementing an online program for improvement of cognitive, emotional, and functional status in post-COVID condition.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
15 Mar 2024
Start date
3 Oct 2023
Primary completion date
5 Sept 2024
Lead sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
NCT number
NCT06315894

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 3 Oct 2023 to the primary completion date, 5 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Current participation in a trial or program for improvement of post-COVID symptoms.
  • Any condition that in the opinion of the investigator would make study participation unsafe, complicate interpretation of study outcome data, interfere with achieving the study objectives, or otherwise could impair the subject's ability to complete the study.

Other

  • Inability to undergo the neuropsychological tests or complementary study assessments.

Who the study is looking for

  • Presenting Post-COVID Syndrome, defined as presenting 3 or more symptoms associated with post-COVID condition for at least 3 months.
  • Age of 18-65 years old.
  • Presence of self-reported cognitive complaints associated with post-COVID infection.
  • Positive and favorable attitude on the use of electronic devices.
  • Will to participate in a stimulation program for improvement of cognitive symptoms.
  • Availability of cell phone and computer or tablet with the minimum technical features considered.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Germans Trias I Pujol Hospital
Coordinator of this site? Confirm its status
BadalonaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.